Stericycle Inc (SRCL) is Reiterated by Barrington Research to Outperform, Lowers Price Target to $ 88

Stericycle Inc (SRCL) was Reiterated by Barrington Research to “Outperform” while Lowering the Price Target of the company shares to $ 88 from a previous price target of $100 . Barrington Research advised their investors in a research report released on Oct 5, 2016.

Many Wall Street Analysts have commented on Stericycle Inc. Shares were Reiterated by Wedbush on Sep 22, 2016 to “Neutral” and Lowered the Price Target to $ 85 from a previous price target of $95 .Stericycle Inc was Downgraded by Northcoast to ” Neutral” on Sep 20, 2016. Shares were Reiterated by RBC Capital Mkts on Sep 19, 2016 to “Underperform” and Lowered the Price Target to $ 77 from a previous price target of $89 .

On the company’s financial health, Stericycle Inc reported $1.18 EPS for the quarter, based on the information available during the earnings call on Jul 28, 2016. Analyst had a consensus estimate of $1.18. The company had revenue of $891.60 million for the quarter, compared to analysts expectations of $911.39 million. The company’s revenue was up 24.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.

Stericycle Inc closed down -2.42 points or -3.03% at $77.34 with 13,70,591 shares getting traded on Tuesday. Post opening the session at $79.87, the shares hit an intraday low of $77.1 and an intraday high of $79.96 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

In a different news, on Sep 16, 2016, John P Schetz (EVP & General Counsel) sold 1,398 shares at $81.85 per share price. According to the SEC, on Aug 19, 2016, Rodney F Dammeyer (director) sold 10,188 shares at $85.50 per share price. On Jul 11, 2016, Mark C Miller (director) sold 34,835 shares at $104.52 per share price, according to the Form-4 filing with the securities and exchange commission.

Stericycle Inc. is engaged in the business of providing regulated and compliance solutions to healthcare and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal and a variety of training consulting recall/return communication and compliance services which include training consulting inbound/outbound communications data reporting and other regulatory compliance services. The Company operates regulated waste management networks in the United States Argentina Brazil Canada Chile Ireland Japan Mexico Portugal Romania South Korea Spain and the United Kingdom. The Company operates through two segments: United States and International. The Company’s networks include a total of 181 processing facilities 214 transfer sites and 97 other service facilities. Its regulated waste processing technology is primarily autoclaving. The Company also uses incineration and electro-thermal-deactivation system (ETD).

Stericycle Inc

Leave a Reply

Stericycle Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stericycle Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.